Eli Lilly and Company

Associate Vice President - Global Product Complaints Management

Indianapolis, Indiana, United States

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceutical, Healthcare, Quality AssuranceIndustries

Requirements

The ideal candidate should possess an Associate's degree or higher, with a preference for a degree in a related field such as Business Administration, Quality Assurance, or a scientific discipline. Significant experience in quality management, preferably within the pharmaceutical or healthcare industry, is required, along with demonstrated leadership abilities and a strong understanding of global regulatory requirements.

Responsibilities

As the Associate Vice President - Global Product Complaints Management, you will lead a team responsible for overseeing the global consumer product complaint quality system and related product safety surveillance activities. This includes developing global complaint management strategies, processing product complaints, analyzing information, developing HR policies to ensure compliance, conducting audits, delivering training, advising management on risk mitigation, partnering with senior leadership, building relationships with business components, assuring resource allocation, monitoring the regulatory environment, and continuously optimizing the quality system.

Skills

Complaint Management
Quality Management
Regulatory Requirements
Risk Mitigation
Auditing
Training
Strategic Planning
Leadership
Stakeholder Management

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI